118-LB: The Antipsychotic D2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA—3-Ketoacid CoA transferase
SEYED AMIRHOSSEIN TABATABAEI DAKHILI, John R. Ussher(University of Alberta), PETER A. CRAWFORD, Christina T. Saed(University of Alberta), Rabih Abou Farraj(University of Alberta), CRYSTAL LEE, KUNYAN YANG, Farah Eaton(University of Alberta), KESHAV GOPAL, Amanda A. Greenwell(University of Alberta), Jordan S. F. Chan(University of Alberta), MARK GLOVER, CARLOS A. VELAZQUEZ, RAMI AL BATRAN
Cited by 0
Related Papers
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
|Cardiovascular Research|2019|195
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue
|Diabetes|2022|62
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
|Frontiers in Cardiovascular Medicine|2018|42
The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity
|JCI Insight|2019|18
Ketone ester administration improves glycemia in obese mice
|American Journal of Physiology-Cell Physiology|2023|18